2013. C-Terminal-PEDF Reduces IC50 Doses and Chemoresistant Population of CD133 and BCRP1-Positve Cancer Stem Like Cells. Journal of Analytical Oncology. 2, 4 (Dec. 2013), 195–208. DOI:https://doi.org/10.6000/1927-7229.2013.02.04.2.